Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001209191-22-023352

Options or other derivatives

  • Chief Operating Officer acquired 61,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Delaney Brendan · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-01 Grant or award : show line 1 in the form Stock option (right to buy) +61,000 61,000 D
Loading xslF345X03/doc4.xml…